PPD, Inc.(PPD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PPD PPD, Inc.

停牌 04-17 16:00:00 EDT

47.28

+0.00

0.00%

最高47.28	最低47.28	成交量0.00
今开47.28	昨收47.28	日振幅0.00%
总市值166.14亿	流通市值55.70亿	总股本3.51亿
成交额0.00	换手率0.00%	流通股本1.18亿
市净率-39.14	ROE-27.30%	每股收益1.01
52周最高47.28	52周最低47.28	市盈率47.03
股息0.00	股息收益率0.00	ROA6.39%

北京优虎网络科技有限公司

{"stockData":{"symbol":"PPD","market":"US","secType":"STK","nameCN":"PPD, Inc.","latestPrice":47.28,"timestamp":1744920000000,"preClose":47.28,"halted":3,"volume":0,"delay":0,"floatShares":117802105,"shares":351394547,"eps":1.005366,"marketStatus":"停牌","change":0,"latestTime":"04-17 16:00:00 EDT","open":47.28,"high":47.28,"low":47.28,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.005366,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":0,"adr":0,"listingDate":1580965200000,"exchange":"NASDAQ","adjPreClose":47.28,"volumeRatio":1.2485646409899478,"impliedVol":0.1492,"impliedVolPercentile":0},"requestUrl":"/m/hq/s/PPD","defaultTab":"news","newsList":[{"id":"2529099847","title":"拍拍贷母公司信也股权曝光：顾少丰持股33.8% 有65.9%投票权","url":"https://stock-news.laohu8.com/highlight/detail?id=2529099847","media":"雷递网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2529099847?lang=zh_cn&edition=full","pubTime":"2025-04-21 15:23","pubTimestamp":1745220235,"startTime":"0","endTime":"0","summary":"拍拍贷母公司信也科技（FinVolution，股票代码：“FINV”)日前递交20-F文件，文件显示，截至2025年3月31日，信也科技董事长、首席创新官顾少丰通过PPD Investment Limited持股33.8%，有65.9%投票权。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250421/6388084564297661973610064.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20250421/6388084564297661973610064.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n29749/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["BK4121","PPD","BK4561","BK4530"],"gpt_icon":0},{"id":"2483348383","title":"国联证券：重磅临床数据迭出 PPD-(L)1双靶点药物再掀免疫治疗热潮","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348383","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348383?lang=zh_cn&edition=full","pubTime":"2024-11-15 15:55","pubTimestamp":1731657311,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国联证券发布研报称，全球重磅临床数据迭出，对肿瘤免疫二代疗法关注度激增，免疫检查点抑制剂PD-1单抗开启癌症治疗新时代，因其泛癌种属性推动了多个大单品的诞生。为突破单一免疫疗法的局限性，中国药企在全球掀起了以PD-1为骨架的双靶“二代免疫治疗”药物开发热潮。康方生物和普米斯生物分别领衔全球PD1/VEGF和PD-L1/VEGF双抗药物开发，剑指K药多项适应症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1211454.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["601456","01456","PPD","L","BK4561","BK4107","BK4585","BK4588","BK0276","LU0053666078.USD","BK4121","BK1564","BK1147","BK4530"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ppdi.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PPD, Inc.（前身为Eagle Holding Company I）于2017年4月13日在特拉华州成立。该公司是为生物制药行业提供药物开发服务的领先提供商，致力于帮助其客户带来新药。给世界各地的病人该公司从事药物开发服务业务已有30多年的历史，为制药，生物技术，医疗设备和政府机构以及其他行业参与者提供全面的临床开发和实验室服务。 2018年，该公司为2018年研发支出排名的全球前50名生物制药公司提供了服务，并参与了66项药物批准。该公司还参与了2018年所有十大畅销药物的开发，按2018年收入排名。自2014年以来，该公司还通过其PPD Biotech模型与不断发展的生物技术领域的300多家公司合作，该模型专门为满足该客户群的独特需求而构建。","exchange":"NASDAQ","name":"PPD, Inc.","nameEN":"PPD, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PPD, Inc.(PPD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PPD, Inc.(PPD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PPD, Inc.,PPD,PPD, Inc.股票,PPD, Inc.股票老虎,PPD, Inc.股票老虎国际,PPD, Inc.行情,PPD, Inc.股票行情,PPD, Inc.股价,PPD, Inc.股市,PPD, Inc.股票价格,PPD, Inc.股票交易,PPD, Inc.股票购买,PPD, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PPD, Inc.(PPD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PPD, Inc.(PPD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}